Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Translation of the intrinsically disordered protein α-synuclein is inhibited by a small molecule targeting its structured mRNA
Peiyuan Zhang, Hye-Jin Park, Jie Zhang, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 3, pp. 1457-1467
Open Access | Times Cited: 92

Showing 1-25 of 92 citing articles:

Targeting RNA structures with small molecules
Jessica L. Childs‐Disney, Xueyi Yang, Quentin M. R. Gibaut, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 10, pp. 736-762
Open Access | Times Cited: 353
RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges
Ai‐Ming Yu, Young Hee Choi, Mei‐Juan Tu
Pharmacological Reviews (2020) Vol. 72, Iss. 4, pp. 862-898
Open Access | Times Cited: 306
Small molecule recognition of disease-relevant RNA structures
Samantha M. Meyer, Christopher C. Williams, Yoshihiro Akahori, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 19, pp. 7167-7199
Open Access | Times Cited: 141
Parkinson's disease: Alterations in iron and redox biology as a key to unlock therapeutic strategies
Linlin Ma, Mahan Gholam Azad, Mahendiran Dharmasivam, et al.
Redox Biology (2021) Vol. 41, pp. 101896-101896
Open Access | Times Cited: 104
Therapeutics in the Pipeline Targetingα-Synuclein for Parkinson's Disease
Hilary Grosso Jasutkar, Stephanie Oh, M. Maral Mouradian
Pharmacological Reviews (2022) Vol. 74, Iss. 1, pp. 207-237
Open Access | Times Cited: 70
Decreasing the intrinsically disordered protein α-synuclein levels by targeting its structured mRNA with a ribonuclease-targeting chimera
Yuquan Tong, Peiyuan Zhang, Xueyi Yang, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 2
Open Access | Times Cited: 18
How We Think about Targeting RNA with Small Molecules
Matthew G. Costales, Jessica L. Childs‐Disney, Hafeez S. Haniff, et al.
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 17, pp. 8880-8900
Open Access | Times Cited: 137
Ribonuclease recruitment using a small molecule reduced c9ALS/FTD r(G 4 C 2 ) repeat expansion in vitro and in vivo ALS models
Jessica A. Bush, Haruo Aikawa, Rita Fuerst, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 617
Open Access | Times Cited: 61
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
Sindhu Menon, Sabrina E.M. Armstrong, Amir Mohammad Hamzeh, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 47
Transcriptome-Wide Mapping of Small-Molecule RNA-Binding Sites in Cells Informs an Isoform-Specific Degrader of QSOX1 mRNA
Yuquan Tong, Quentin M. R. Gibaut, Warren B. Rouse, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 26, pp. 11620-11625
Open Access | Times Cited: 45
Proximity-Induced Nucleic Acid Degrader (PINAD) Approach to Targeted RNA Degradation Using Small Molecules
Sigitas Mikutis, Maria Rebelo, Eliza Yankova, et al.
ACS Central Science (2023) Vol. 9, Iss. 5, pp. 892-904
Open Access | Times Cited: 41
RNA–Small-Molecule Interaction: Challenging the “Undruggable” Tag
Jaskirat Kaur, Akanksha Sharma, Poonam Mundlia, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 6, pp. 4259-4297
Closed Access | Times Cited: 10
Design, Optimization, and Study of Small Molecules That Target Tau Pre-mRNA and Affect Splicing
Jonathan L. Chen, Peiyuan Zhang, Masahito Abe, et al.
Journal of the American Chemical Society (2020) Vol. 142, Iss. 19, pp. 8706-8727
Open Access | Times Cited: 59
Targeting α-Synuclein for PD Therapeutics: A Pursuit on All Fronts
Margaux Teil, Marie-Laure Arotçarena, Emilie Faggiani, et al.
Biomolecules (2020) Vol. 10, Iss. 3, pp. 391-391
Open Access | Times Cited: 56
Design of small molecules targeting RNA structure from sequence
Andrei Ursu, Jessica L. Childs‐Disney, Ryan J. Andrews, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 20, pp. 7252-7270
Open Access | Times Cited: 55
Anin silicomap of the SARS-CoV-2 RNA Structurome
Ryan J. Andrews, Jake M. Peterson, Hafeez S. Haniff, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 54
RNA–ligand molecular docking: Advances and challenges
Yuanzhe Zhou, Yangwei Jiang, Shi‐Jie Chen
Wiley Interdisciplinary Reviews Computational Molecular Science (2021) Vol. 12, Iss. 3
Open Access | Times Cited: 51
From Junk to Function: LncRNAs in CNS Health and Disease
Rafaela Policarpo, Annerieke Sierksma, Bart De Strooper, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 47
Prion-Like Proteins in Phase Separation and Their Link to Disease
Macy L. Sprunger, Meredith E. Jackrel
Biomolecules (2021) Vol. 11, Iss. 7, pp. 1014-1014
Open Access | Times Cited: 46
Protein degradation by human 20S proteasomes elucidates the interplay between peptide hydrolysis and splicing
Wai Tuck Soh, Hanna P. Roetschke, John A. Cormican, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Heterobifunctional small molecules to modulate RNA function
Sandra Kovachka, Yuquan Tong, Jessica L. Childs‐Disney, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 5, pp. 449-463
Closed Access | Times Cited: 6
Expanding the DNA-encoded library toolbox: identifying small molecules targeting RNA
Qiuxia Chen, You Li, Chunrong Lin, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 12, pp. e67-e67
Open Access | Times Cited: 26
Transfer of neuron-derived α-synuclein to astrocytes induces neuroinflammation and blood–brain barrier damage after methamphetamine exposure: Involving the regulation of nuclear receptor-associated protein 1
Jian Huang, Jiuyang Ding, Xiaohan Wang, et al.
Brain Behavior and Immunity (2022) Vol. 106, pp. 247-261
Closed Access | Times Cited: 26
Fragment-Based Approaches to Identify RNA Binders
Blessy M. Suresh, Amirhossein Taghavi, Jessica L. Childs‐Disney, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 10, pp. 6523-6541
Open Access | Times Cited: 15
Drugging RNA
Ken Garber
Nature Biotechnology (2023) Vol. 41, Iss. 6, pp. 745-749
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top